Featured Interview: CEO Alex Wasyl of Nexien BioPharma, Inc. (OTCQB: NXEN)

Featured Interview: CEO Alex Wasyl of Nexien BioPharma, Inc. (OTCQB: NXEN)

    CEO Alex Wasyl of Nexien BioPharma, Inc. (OTCQB: NXEN) joins Stock Day to discuss recent acquisition, consolidation, and being engaged in the formulation, development, and commercialization of cannabinoid based drugs.


The CEOs interviewed on the Stock Day Podcast did not incur any charges for their time with Uptick Newswire CEO Everett Jolly. Contact us at (602) 441-3474 if you would like further information.

Close Menu